November 15, 2023 Uncategorized US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives Read More
September 14, 2023 Uncategorized BetterLife Pharma to Host Investors Update Call on September 18, 2023 Read More
September 12, 2023 Uncategorized BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001 Read More
September 5, 2023 Uncategorized BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement Read More
July 13, 2023 Uncategorized BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement Read More
June 27, 2023 Uncategorized BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives Read More
June 22, 2023 Uncategorized BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada Read More
